Shares of Bodal Chemicals are likely to remain in focus after the company reported a sharp improvement in profitability for the quarter ended March 31, 2026, supported by strong revenue growth and margin expansion.
The company reported Q4 FY26 revenue of Rs 588.02 crore, compared to Rs 450.87 crore in the corresponding quarter last year, registering a 30.42% year-on-year growth. Revenue also rose 20.11% sequentially.
EBITDA for the quarter stood at Rs 68.56 crore against Rs 47.26 crore in Q4 FY25, reflecting a 45.09% year-on-year increase. On a sequential basis, EBITDA surged over 211%. EBITDA margin improved to 11.66% from 10.48% in the year-ago quarter and 4.50% in the December quarter, indicating better operational efficiency and improved cost management.
Profit before tax (PBT) came in at Rs 36.07 crore, sharply higher than Rs 11.60 crore reported in the corresponding quarter last year. The company’s net profit rose to Rs 32.06 crore in Q4 FY26 from Rs 14.50 crore in Q4 FY25, marking a 121.04% year-on-year jump.
On a sequential basis, PAT witnessed a significant recovery from a weak previous quarter, rising over 13,000%.
Other income for the quarter stood at Rs 2.59 crore compared to Rs 2.35 crore in the year-ago period. The company had reported significantly higher other income of Rs 15.09 crore in Q3 FY26.
According to the exchange filing, consolidated Q4 revenue stood at Rs 577 crore versus Rs 445 crore a year ago, while EBITDA came in at Rs 69.7 crore against Rs 49.8 crore. EBITDA margin improved to 12.1% from 11.18% in the corresponding quarter last year.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.